Key result
Apolipoprotein E alleles show no clear link to breast or prostate cancer risk.
Observational
Answers are grounded in this paper and cite their sources.
Although many studies have shown an increased risk of death from cancer in subjects with low plasma cholesterol concentrations, the underlying mechanism between low blood cholesterol and cancer is unclear. Apolipoprotein E is a central regulatory protein in cholesterol metabolism, and recent studies have shown that apolipoprotein E is a potent inhibitor of angiogenesis and tumour cell growth.1 Apolipoprotein E has three common isoforms, E2, E3, and E4, which are coded by the alleles e2, e3 and e4, respectively. The e4 allele is associated with high serum total and low density lipoprotein cholesterol concentrations.2 Recently, it was suggested that the apolipoprotein E e4 allele may protect from carcinoma and adenoma of the colon.3 We hypothesised that the apolipoprotein E polymorphism could also be associated with other cancer types. The main question of this study was whether the apolipoprotein E allele distribution is different in …
No takes yet. Share an insight, caveat, or question.
Mari Niemi (2000) conducted an observational in Breast and prostate cancer. Apolipoprotein E polymorphism (e2, e3, e4 alleles) and plasma cholesterol was evaluated on Breast and prostate cancer occurrence across apolipoprotein E allele distributions.
Synapse has enriched 10 related papers. Consider them for comparative context: